Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

FBP Appreciation & Income Opportunities Fund (FBPBX)

15.15
Net Asset Value
-0.85%
1 Day
-7.06%
Year-to-Date
Overall Morningstar Rating
Aggressive allocation
Style or Category
No Load
Sales Expenses
1.06%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long term capital appreciation and current income, assuming a moderate level of investment risk. The fund seeks to achieve its objectives by investing in a portfolio of both equity and fixed income securities. It will invest primarily in companies with market capitalizations of $1 billion or more. Fixed income securities include corporate debt obligations, U.S. government obligations and shares of ETFs that invest primarily in corporate debt obligations and U.S. government obligations.

Performance

1 month-6.37% 3 years+2.70%
3 months-11.31% 5 years+3.08%
1 year-13.76% Since inception+6.81%
Data through --

Peer Comparisonvs. Aggressive allocation

 FBPBXCategory
Performance 5-yr return+3.08%+6.69%
Expense ratio1.06%1.36%
Risk 5 year sharpe ratio0.380.53
Net assets$29.9M$902.8M
Average market cap$52.1B$35.1B
Average P/E14.917.8
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFlippin, Bruce & Porter Funds
Fund manager & tenureJohn Bruce / 26 Years
Minimal initial investment$5,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock72.79%
Cash16.72%
Fixed income5.31%
International stock5.18%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 19.53%
Consumer service 12.02%
Consumer goods 11.45%
Industrial materials 10.96%
Energy 10.53%
Top 10 Holdings
Portfolio weighting
BAC Bank of America3.27%
CSCO Cisco3.19%
MET Metlife2.87%
PFE Pfizer2.67%
JNJ Johnson & Johnson2.58%
LNC Lincoln National Corp2.52%
MSFT Microsoft2.29%
-- 2.26%
JPM JPMorgan Chase2.22%
MRK Merck2.10%

Partner Offers